The use of biosimilars is increasing. There are currently 40 already approved by the FDA. Biosimilars are a less expensive version of a brand-name biologic
According to a recent survey of 1,200 healthcare providers by the National Center for Primary Care at the Morehouse School of Medicine, physicians have been slow to adopt digital health technologies such as mobile apps, wearables, and remote patient monitoring. These tools allow providers to better manage acute and chronic conditions and reduce patients’ travel costs and infection risk.
We all hate waiting in line. It has been called a “timeless form of torture” commemorated by famous authors, including Dr. Suess in the dreaded
Many employers self-fund and go at risk for drug costs, and this gives them more control. But for years now, the rising cost of medication has caused employers significant grief. There may finally be some help from the Centers for Medicare and Medicaid Services (CMS). In 2019, the CMS got serious about transparency and introduced a new rule requiring health plans to report the cost of prescription drugs on an annual basis.
Austin health-tech startup is growing quickly amid rampant tech layoffs. AUSTIN, TX, March 9, 2023 – RazorMetrics, a rapidly growing healthcare technology company focused on
The recently passed Inflation Reduction Act gives the Center for Medicaid and Medicare Services (CMS) the power to negotiate drug prices, which had only been allowed for private companies and health plans previously.
The good news is the Inflation Reduction Act, which puts a $35 cap on monthly insulin prices, went into effect on Jan. 1. The bad
Whenever Congress or state legislatures start talking about capping high drug costs or other legislative solutions, pharmaceutical companies argue that these laws are counterproductive. They argue that they must charge exorbitant prices for new drugs because it pays for the next class of cures.
This past Sunday was National App day. National App day was created by CJ Thompson – founder of the mobile marketing agency Platinum Edge Media
What makes a drug fall into the “specialty” drug category is a combination of several factors. First, they tend to be very expensive. This is because they were recently approved, meaning they are under an active patent with no generic or biosimilar version available.
And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.
